[Federal Register Volume 69, Number 228 (Monday, November 29, 2004)]
[Notices]
[Page 69379]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-26250]



[[Page 69379]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b9c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, SBSR Special Review.
    Date: November 23, 2004.
    Time: 12 p.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Mehrdad M. Tondravi, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4108, MSC 7814, Bethesda, MD 
20892, (301)-435-1173, <a href="/cdn-cgi/l/email-protection#36425958524457405b7655454418585f5e18515940"><span class="__cf_email__" data-cfemail="65110a0b0117041308250616174b0b0c0d4b020a13">[email protected]</span></a>.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Smoking Cessation Intervention and Health.
    Date: November 29, 2004.
    Time: 9 a.m. to 11 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Michael Micklin, PhD, Chief, RPHB IRG, Center 
for Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 3136, MSC 7759, Bethesda, MD 20892, (301)-435-1258, 
<a href="/cdn-cgi/l/email-protection#85e8ece6eee9ecebe8c5e6f6f7abebecedabe2eaf3"><span class="__cf_email__" data-cfemail="234e4a40484f4a4d4e634050510d4d4a4b0d444c55">[email protected]</span></a>.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Caregiver Health.
    Date: November 30, 2004.
    Time: 10:30 a.m. to 11:30 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Karen Lechter, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3128, MSC 7759, Bethesda, MD 
20892, (301)-496-0726, <a href="/cdn-cgi/l/email-protection#375b52545f4352455c7754444519595e5f19505841"><span class="__cf_email__" data-cfemail="f79b92949f8392859cb7948485d9999e9fd9909881">[email protected]</span></a>.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, RPHB-B (07): Cancer and Mental Health.
    Date: November 30, 2004.
    Time: 12 p.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Karen Lechter, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3128, MSC 7759, Bethesda, MD 
20892, (301)-496-0726, <a href="/cdn-cgi/l/email-protection#5e323b3d362a3b2c351e3d2d2c7030373670393128"><span class="__cf_email__" data-cfemail="365a53555e4253445d7655454418585f5e18515940">[email protected]</span></a>.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Artemin, Noceciptors, Bacteriorhodopsin and Photodegradation.
    Date: December 3, 2004.
    Time: 10:30 a.m. to 11:30 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Syed Husain, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5216, MSC 7850, Bethesda, MD 
20892, (301)-435-1224, <a href="/cdn-cgi/l/email-protection#3c54494f5d55524f7c5f4f4e12525554125b534a"><span class="__cf_email__" data-cfemail="f29a8781939b9c81b2918180dc9c9b9adc959d84">[email protected]</span></a>.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, ZRG1 BDA A 90S: Cadmium Effects on Testicle Development.
    Date: December 9, 2004.
    Time: 4 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Sherry L. Dupere, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5136, MSC 7843, Bethesda, MD 
20892, (301)-435-1021, <a href="/cdn-cgi/l/email-protection#d8bcada8bdaabdab98bbabaaf6b6b1b0f6bfb7ae"><span class="__cf_email__" data-cfemail="9efaebeefbecfbeddefdedecb0f0f7f6b0f9f1e8">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Novel Therapy Against Glioma.
    Date: December 15, 2004.
    Time: 12 p.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Elaine Sierra-Rivera, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6184, MSC 7804, Bethesda, MD 
20892, (301)-435-1779, <a href="/cdn-cgi/l/email-protection#681a011e0d1a091b0d280b1b1a46060100460f071e"><span class="__cf_email__" data-cfemail="196b706f7c6b786a7c597a6a6b37777071377e766f">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: November 18, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-26250 Filed 11-26-04; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>